Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
On the manufacturing and infrastructure front, Novo announced a 432 million (~$500 million) expansion of the companys Athlone, Ireland, facility to build capacity for oral GLP-1 production targeted at non-US markets, and larger investments in Brazil to boost injectable output, moves aimed at alleviating supply constraints and future demand
KoethRAWangZLevisonBSBuffaJAOrgESheehyBTet al
Anti-inflammatory effect of Clostridium butyricum -derived extracellular vesicles in ulcerative colitis: Impact on host microRNAs expressions and gut microbiome profiles
H., Gonalves, J
Recent progress in mRNA cancer vaccines
Tirzepatide activates both GIP and GLP-1 receptors
US$ 20.10
US$ 23.19
US$ 21.17
US$ 20.31
US$ 21.62
US$ 28.79
US$ 29.94
US$ 29.96
US$ 26.61
US$ 20.89
US$ 28.21
US$ 23.88
US$ 23.01
